Ratings by Chardan (Geulah Livshits)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/5/2026 | Climb Bio | CLYM | New Coverage | Buy (N/A) |
8.91 (12.30) |
38.05% | Details | |
| 4/27/2026 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2026 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2025 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Prime Medicine | PRME | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2025 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2025 | Prime Medicine | PRME | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2025 | Palvella Therapeutics | PVLA | New Coverage | Buy (N/A) |
20.51 (118.68) |
478.64% | Details | |
| 3/20/2025 | Prime Medicine | PRME | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2025 | Cargo Therapeutics | CRGX | Downgrade | Neutral (Buy) |
13.65 (4.47) |
-67.25% | Details | |
| 12/13/2024 | Editas Medicine | EDIT | Downgrade | Neutral (Buy) |
1.89 (2.76) |
46.03% | Details | |
| 12/4/2024 | Senti Biosciences, Inc. | SNTI | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2024 | Editas Medicine | EDIT | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2024 | 4D Molecular Therapeutics | FDMT | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2024 | 4D Molecular Therapeutics | FDMT | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2024 | Cargo Therapeutics | CRGX | New Coverage | Buy (N/A) |
15.37 (13.65) |
-11.19% | Details | |
| 4/22/2024 | Prime Medicine | PRME | New Coverage | Buy (N/A) |
4.51 (3.23) |
-28.38% | Details | |
| 3/15/2024 | Immuneering Corporation | IMRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2024 | Metagenomi Inc | MGX | New Coverage | Buy (N/A) |
12.04 (1.24) |
-89.7% | Details | |
| 2/5/2024 | 4D Molecular Therapeutics | FDMT | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2023 | Lexeo Therapeutics | LXEO | New Coverage | Buy (N/A) |
11.00 (4.92) |
-55.27% | Details | |
| 11/15/2023 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Century Therapeutics | IPSC | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2023 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 7/5/2023 | 4D Molecular Therapeutics | FDMT | New Coverage | Buy (N/A) |
17.86 (11.60) |
-35.05% | Details | |
| 6/13/2023 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2023 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2023 | Tenaya Therapeutics Inc | TNYA | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2023 | Immuneering Corporation | IMRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2023 | Tenaya Therapeutics Inc | TNYA | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2022 | Century Therapeutics | IPSC | New Coverage | Buy (N/A) |
5.67 (2.41) |
-57.5% | Details | |
| 12/6/2022 | Achilles Therapeutics | ACHL | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2022 | Editas Medicine | EDIT | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | PDS Biotechnology Corp | PDSB | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2022 | Senti Biosciences, Inc. | SNTI | New Coverage | Buy (N/A) |
1.52 (0.92) |
-39.47% | Details | |
| 8/10/2022 | Immatics | IMTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2022 | Vascular Biogenics Ltd | VBLT | Downgrade | Neutral (Buy) |
2.05 (0.16) |
-92.2% | Details | |
| 7/8/2022 | Immuneering Corporation | IMRX | New Coverage | Buy (N/A) |
5.65 (4.54) |
-19.65% | Details | |
| 5/25/2022 | SQZ Biotechnologies | SQZ | New Coverage | Buy (N/A) |
3.35 (0.44) |
-86.87% | Details | |
| 3/1/2022 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2022 | LogicBio Therapeutics | LOGC | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2021 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2021 | Immatics | IMTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2021 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2021 | Regenxbio Inc. | RGNX | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2021 | Renovacor, Inc. | RCOR | New Coverage | Buy (N/A) |
9.05 (3.20) |
-64.64% | Details | |
| 9/24/2021 | Solid Biosciences | SLDB | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2021 | Tenaya Therapeutics Inc | TNYA | New Coverage | Buy (N/A) |
23.35 (0.73) |
-96.87% | Details | |
| 7/30/2021 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2021 | PDS Biotechnology Corp | PDSB | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2021 | PDS Biotechnology Corp | PDSB | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2021 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2021 | Achilles Therapeutics | ACHL | New Coverage | Buy (N/A) |
16.60 (1.48) |
-91.08% | Details | |
| 2/10/2021 | Editas Medicine | EDIT | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2021 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2021 | Cabaletta Bio Inc. | CABA | New Coverage | Buy (N/A) |
12.93 (3.02) |
-76.64% | Details | |
| 1/6/2021 | Vincerx Pharma | VINC | New Coverage | Buy (N/A) |
19.45 (0.10) |
-99.49% | Details | |
| 12/10/2020 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2020 | Immunome Inc. | IMNM | New Coverage | Buy (N/A) |
11.74 (19.33) |
64.65% | Details | |
| 10/6/2020 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2020 | Replimune Group | REPL | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | ARYA Sciences Acquisition Corp. | ARYA | New Coverage | Buy (N/A) |
13.55 (11.16) |
-17.64% | Details | |
| 2/24/2020 | Homology Medicines | FIXX | New Coverage | Buy (N/A) |
17.68 (0.93) |
-94.74% | Details | |
| 11/14/2019 | Vascular Biogenics Ltd | VBLT | Upgrade | Buy (Neutral) |
1.26 (0.16) |
-87.3% | Details | |
| 11/8/2019 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2019 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2019 | PDS Biotechnology Corp | PDSB | New Coverage | Buy (N/A) |
3.10 (0.91) |
-70.65% | Details | |
| 9/13/2019 | Tocagen Inc. | TOCA | Downgrade | Neutral (Buy) |
0.93 (1.26) |
35.48% | Details | |
| 7/23/2019 | Replimune Group | REPL | New Coverage | Buy (N/A) |
12.11 (11.42) |
-5.7% | Details | |
| 5/20/2019 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2019 | Editas Medicine | EDIT | Maintain | Buy (N/A) |
|
Details |
